Why the Difference Between Risk and Hazard Matters for Nanotechnology
23 April 2007
Scientific progress is a balancing act: Weigh the empirical evidence and determine the appropriate balance between allowing new technologies and protecting public health. Periodically however, development is obstructed by fear diminishing physical data. In this article, Mark Mansour discusses the idea that nanotechnology is poised to turn a bad trend of regulators, preferring to use “precautionary principles” to regulate based on means of production rather on the safety of the product, on its head and show the world that regulation based on empirical data, rather than on fear, provides the best hope for a safe future.
Copyright 2007 Small Times, PennWell Corp.
Copyright 2007 Small Times, PennWell Corp.
Related Insights
19 May 2025
The Path & The Practice
Podcast Episode 125: Kimberly Klinsport, Partner
This episode of The Path & The Practice features a conversation with Kimberly Klinsport, a litigation partner in Foley’s Los Angeles office where she is also the Office Managing Partner.
19 May 2025
Foley Career Perspectives
Inside Foley's 2025 Senior Counsel Meeting: Building Paths to Partnership
In April, Foley welcomed 90 senior counsel from 18 offices to Chicago for a dynamic three-day program focused on building a strong foundation for their path to partnership and reaffirming the firm’s commitment to their career success.
27 May 2025
Events
The RIF Roadmap: Tools and Tactics for a Smooth and Compliant Transition
Join us for an insightful discussion on proactive workforce planning in today's dynamic economic and regulatory landscape.